BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 14741426)

  • 1. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).
    Ringheim GE; Conant K
    J Neuroimmunol; 2004 Feb; 147(1-2):43-9. PubMed ID: 14741426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease, the neuroimmune axis, and viral infection.
    Itzhaki RF; Wozniak MA
    J Neuroimmunol; 2004 Nov; 156(1-2):1-2. PubMed ID: 15526402
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune responses in neurodegenerative diseases.
    Shrestha R; Shakya Shrestha S; Millingtona O; Brewer J; Bushell T
    Kathmandu Univ Med J (KUMJ); 2014; 12(45):67-76. PubMed ID: 25219999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.
    Lang Y; Chu F; Shen D; Zhang W; Zheng C; Zhu J; Cui L
    Mediators Inflamm; 2018; 2018():1549549. PubMed ID: 29849483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in neurodegenerative diseases.
    Amor S; Puentes F; Baker D; van der Valk P
    Immunology; 2010 Feb; 129(2):154-69. PubMed ID: 20561356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases.
    González H; Elgueta D; Montoya A; Pacheco R
    J Neuroimmunol; 2014 Sep; 274(1-2):1-13. PubMed ID: 25091432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease.
    Delpech JC; Herron S; Botros MB; Ikezu T
    Trends Neurosci; 2019 May; 42(5):361-372. PubMed ID: 30926143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics.
    Li Z; Zhang Y; Ji M; Wu C; Zhang Y; Ji S
    Biomed Pharmacother; 2024 Jul; 176():116777. PubMed ID: 38795640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer's Disease.
    Schwartz M; Peralta Ramos JM; Ben-Yehuda H
    J Immunol; 2020 Jan; 204(2):243-250. PubMed ID: 31907265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.
    Gerhardt S; Mohajeri MH
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29857583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases.
    Balestri W; Sharma R; da Silva VA; Bobotis BC; Curle AJ; Kothakota V; Kalantarnia F; Hangad MV; Hoorfar M; Jones JL; Tremblay MÈ; El-Jawhari JJ; Willerth SM; Reinwald Y
    J Neuroinflammation; 2024 Jan; 21(1):32. PubMed ID: 38263227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy: An emerging treatment option for neurodegenerative diseases.
    Mukherjee A; Biswas S; Roy I
    Drug Discov Today; 2024 May; 29(5):103974. PubMed ID: 38555032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.
    González H; Pacheco R
    J Neuroinflammation; 2014 Dec; 11():201. PubMed ID: 25441979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.
    Vegeto E; Benedusi V; Maggi A
    Front Neuroendocrinol; 2008 Oct; 29(4):507-19. PubMed ID: 18522863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
    Gelders G; Baekelandt V; Van der Perren A
    J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate Immunity and Neurodegeneration.
    Labzin LI; Heneka MT; Latz E
    Annu Rev Med; 2018 Jan; 69():437-449. PubMed ID: 29106805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.